A Study of Efficacy and Safety Profile With Sub Dermal Single Rod Contraceptive Implant Implanon

Abstract

INTRODUCTION:The development of sub dermal contraceptive implant has been an important improvement in current contraceptive technology and to a good alternative to offer well established contraceptive method. Hormonal implant must show high efficacy, high acceptability and rapid return of fertility after removal by maintaining a sustained release of progesterone, the contraceptive effect of the implant can be obtained with a much smaller daily dose than when administering the same steroid by an oral or intramuscular route. Sub dermal implants are also independent of user compliance which remains a determinant factor in the efficacy of most contraceptive methods. In addition after removal of the hormonal implant, fertility returns almost immediately. They contain only progestogen, these implant may also be used by women who cannot tolerate oestrogen or by women for whom oestrogen is contraindicated. The availability of new innovative contraceptive implant system such as implanon is very important to offer couples alternative methods to plan size of their family more efficiently. OBJECTIVES: To study efficacy and safety profile of single rod sub dermal contraceptive device implant implanon. To evaluate the vaginal bleeding patterns observed during the use of implanon. To assess the acceptability of the contraceptive device as indicated by discontinuation rates. MATERIAL AND METHODS: Study was carried in OBG department of RMC Kanpur on healthy female volunteers having regular menstruation & at least one living child. RESULT: The result of this study was excellent in terms of contraception with pearl index of 0, almost one third cases were having in frequent bleeding episode. CONCLUSION: The study was conducted on 110 women of age 20-35 years with at least one living child and having regular menstrual period, in present study half of cases discontinued implant due to no fix pattern of bleeding and failure was o%, efficacy of this implant is excellent with a pearl index of 0%.

Early contraceptive implants removal and its associated factors among women using implants at a National Referral Hospital, Kampala Uganda

“…Implanon NXT is a single-rod long-acting subdermal hormonal contraceptive for 3-years of use, containing 68 mg etonogestrel [12]. It is made of ethylene-vinyl acetate copolymer with a length of 40 mm and a diameter of 2 mm [13]. Jadelle is a set of two flexible cylindrical implants consisting of dimethylsiloxane/ methyl vinyl siloxane copolymer core enclosed in thinwalled silicone tubing [14].…”

Beyond wearables and implantables: a scoping review of insertable medical devices

“…The APR of insertables typically is achieved in under 30 min [10,20,21], and can be performed in an officebased procedure [18] by unspecialized clinicians, e.g., a nurse or primary care physician, after specific but brief APR training [22]. As general anesthesia is not needed [23], and often even local anesthesia is unnecessary [24], the whole APR procedure is simplified and less risky compared to implantables.…”

“…As general anesthesia is not needed [23], and often even local anesthesia is unnecessary [24], the whole APR procedure is simplified and less risky compared to implantables. In addition, the availability of a specific set of sterile, disposable tools enables standardization of APR to ensure fast and accurate application and positioning at the appropriate skin depth [22], as well as removal at the end of device life. Due to the low risk of tissue damage in the vicinity of the APR site, image guidance (e.g., via ultrasound) is not typically required during 2 An uninfected operative wound in which no inflammation is encountered and the alimentary, genital, respiratory or urinary tracts are not entered [13].…”